Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma In Situ of the Bladder who failed Bacillus Calmette Guerin (NCT01259063)

Background: Standard treatment for BCG-refractory urothelial cancer is radical cystectomy. Identification of active agents is clearly warranted. Objective: To determine a safe dose of oral everolimus in combination with standard intravesical gemcitabine and to evaluate the efficacy of this combinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalbagni, Guido, Benfante, Nicole, Sjoberg, Daniel D., Bochner, Bernard H., Machele Donat, S., Herr, Harry W., Mc Coy, Asia S., Fahrner, Alicia J., Retinger, Caitlyn, Rosenberg, Jonathan E., Bajorin, Dean F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409047/
https://www.ncbi.nlm.nih.gov/pubmed/28516156
http://dx.doi.org/10.3233/BLC-170095

Ejemplares similares

Ejemplares similares